After Hours
$
171.10
Change
-0.08 -0.05%
Volume
Volume 56,474
Aug 12, 2022, 7:59 p.m.
Quotes are delayed by 20 min
Previous close
$ 171.81
$ 171.18
Change
-0.63 -0.37%
Day low
Day high
$168.64
$173.95

52 week low
52 week high
$115.61
$464.85

Market cap
$66.97B
Average volume
5.05M
P/E ratio
5.22
Rev. per Employee
$8.47M
EPS
32.80
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on MRNA
-
Tesla, Amazon Are in Line for a Tax Hit From Climate Bill
- Luisa Beltran
-
Moderna Inc. stock falls Friday, underperforms market
- MarketWatch Automation
-
Moderna Inc. stock underperforms Thursday when compared to competitors
- MarketWatch Automation
-
Moderna Inc. stock rises Wednesday, still underperforms market
- MarketWatch Automation
-
Moderna Inc. stock underperforms Tuesday when compared to competitors
- MarketWatch Automation
-
Pfizer, Moderna Take Different Paths as Vaccine Boom Ends
- Josh Nathan-Kazis
-
Novavax slashes sales guidance in half, stock plunges 34%
- Jeremy C. Owens
-
Moderna Inc. stock falls Monday, underperforms market
- MarketWatch Automation
-
Moderna Inc. stock underperforms Friday when compared to competitors
- MarketWatch Automation
-
Moderna Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
The Bull Market in Biotech Is Still Going Strong
- Josh Nathan-Kazis
-
Moderna CEO: No Pressure for 'Crazy' Deals
- Josh Nathan-Kazis
-
Moderna Inc. stock rises Wednesday, outperforms market
- MarketWatch Automation
- Loading more headlines...
Other News on MRNA
-
Here's How This Beaten-Down Stock Could 10X by 2024
- Motley Fool
-
Wall Street Breakfast: What Moved Markets
- Seeking Alpha
-
GSK: Zantac Litigation Risks Have Been Ignored For Too Long
- Seeking Alpha
-
CDC eases COVID guidance for unvaccinated people
- Seeking Alpha
-
Baron Funds Q2 2022 Report: Letter From Linda
- Seeking Alpha
-
1 Reason to Sell Novavax Stock, and 1 Reason to Buy
- Motley Fool
-
Tracking Baillie Gifford's 13F Portfolio - Q2 2022 Update
- Seeking Alpha
-
GeoVax: Possible Vaccine Advancements In 2 Big Indications
- Seeking Alpha
-
Most Parents Say No to Covid-19 Vaccines for Toddlers
- Jared S. Hopkins
-
Where Will Moderna Be in 1 Year?
- Motley Fool
- Loading more headlines...
Earnings Announcement
Press Releases on MRNA
-
Global Multiple Sclerosis Drugs Market Size Projected To Reach $33 Billion By 2029
- Financial News Media
-
How To Trade Penny Stocks: A Beginner's Guide
- Penny Stocks
-
Moderna Inc. Common Stock MRNA Trading Advice
- Stock Traders Daily
-
- MarketNewsVideo.com
-
- MarketNewsVideo.com
-
Moderna Inc. Common Stock MRNA Trading Report
- Stock Traders Daily
-
mRNA Vaccine and Therapeutics Market Report 2022, Size, Share, Trends and Forecast to 2027
- SUPER MARKET RESEARCH
-
Moderna Inc. Common Stock MRNA Pivots Trading Plans and Risk Controls
- Stock Traders Daily
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com